These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16251880)

  • 41. Utility of fine-needle aspiration cytology and frozen-section examination in the operative management of thyroid nodules.
    Davoudi MM; Yeh KA; Wei JP
    Am Surg; 1997 Dec; 63(12):1084-9; discussion 1089-90. PubMed ID: 9393257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
    Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
    Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
    Zeiger MA; Dackiw AP
    J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules.
    Trimboli P; Guidobaldi L; Amendola S; Nasrollah N; Romanelli F; Attanasio D; Ramacciato G; Saggiorato E; Valabrega S; Crescenzi A
    Endocrine; 2016 Apr; 52(1):39-45. PubMed ID: 26142180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.
    Bartolazzi A; Gasbarri A; Papotti M; Bussolati G; Lucante T; Khan A; Inohara H; Marandino F; Orlandi F; Nardi F; Vecchione A; Tecce R; Larsson O;
    Lancet; 2001 May; 357(9269):1644-50. PubMed ID: 11425367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
    de Matos PS; Ferreira AP; de Oliveira Facuri F; Assumpção LV; Metze K; Ward LS
    Histopathology; 2005 Oct; 47(4):391-401. PubMed ID: 16178894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Galectin-3 in diagnosis of thyroid cancer].
    Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
    Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
    Gasbarri A; Martegani MP; Del Prete F; Lucante T; Natali PG; Bartolazzi A
    J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telomerase activity in "suspicious" thyroid cytology.
    Lerma E; Mora J
    Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galectin-3 for indeterminate thyroid cytology.
    Al Ghuzlan A; Caillou B; Schlumberger M
    Lancet Oncol; 2008 Jun; 9(6):508-10. PubMed ID: 18510984
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative Analysis of Galectin-3 Expression in Benign and Malignant Thyroid Nodules.
    Šamija I; Mateša N; Tadinac S; Jukić T
    Acta Clin Croat; 2020 Jun; 59(Suppl 1):25-31. PubMed ID: 34219881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follicular thyroid carcinoma with signet ring cell morphology: fine-needle aspiration cytology, histopathology, and immunohistochemistry.
    Romero-Rojas AE; Diaz-Perez JA; Mastrodimos M; Chinchilla SI
    Endocr Pathol; 2013 Dec; 24(4):239-45. PubMed ID: 24068558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is galectin-3 a good method for the detection of malignancy in patients with thyroid nodules and a cytologic diagnosis of "follicular neoplasm"? A critical appraisal of the evidence.
    Sanabria A; Carvalho AL; Piana de Andrade V; Pablo Rodrigo J; Vartanian JG; Rinaldo A; Ikeda MK; Devaney KO; Magrin J; Augusto Soares F; Ferlito A; Kowalski LP
    Head Neck; 2007 Nov; 29(11):1046-54. PubMed ID: 17525969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of death due to disease for thyroid fine-needle aspirations of well-differentiated thyroid carcinomas.
    Renshaw AA; Gould EW
    Diagn Cytopathol; 2019 Oct; 47(10):1049-1050. PubMed ID: 31190470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumors.
    Maruta J; Hashimoto H; Yamashita H; Noguchi H; Noguchi S; Kobayashi TK; Tsuneoka H; Takahashi M
    Diagn Cytopathol; 2015 Mar; 43(3):202-9. PubMed ID: 25195571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galectin-3 and CD117 immunocytochemistry in the diagnosis of indeterminate thyroid lesions: A pilot study.
    Dixit S; Diwaker P; Wadhwa N; Arora VK
    Diagn Cytopathol; 2021 Oct; 49(10):1129-1137. PubMed ID: 34297482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis.
    Barroeta JE; Baloch ZW; Lal P; Pasha TL; Zhang PJ; LiVolsi VA
    Endocr Pathol; 2006; 17(3):225-34. PubMed ID: 17308359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.
    de Matos LL; Del Giglio AB; Matsubayashi CO; de Lima Farah M; Del Giglio A; da Silva Pinhal MA
    Diagn Pathol; 2012 Aug; 7():97. PubMed ID: 22888980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.